3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Arthritis, Psoriatic
1
Interventions
guselkumab
3
tofacitinib
1
sonelokimab
1
risankizumab
1
cabozantinib
1
Vaccines
1
Specimen Handling
1
Saline Solution
1
Platinum Compounds
1
Nivolumab
1
Ipilimumab
1
Infliximab
1
Herpes Zoster Vaccine
1
Etanercept
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Arthritis, Psoriatic
×
sonelokimab
×
Clear all
NCT06641089
2026-05-18
IZAR-2
MoonLake Immunotherapeutics AG
Phase 3
Recruiting
600 enrolled